- published: 26 Jan 2014
- views: 453
Nabiximols (USAN, trade name Sativex) is a specific extract of Cannabis that was approved as a botanical drug in the United Kingdom in 2010 as a mouth spray for multiple sclerosis (MS) patients, who can use it to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms; it was developed by the UK company GW Pharmaceuticals. The drug is a pharmaceutical product standardised in composition, formulation, and dose. Its principal active cannabinoid components are the cannabinoids: tetrahydrocannabinol (THC) and cannabidiol (CBD). Each spray delivers a near 1:1 ratio of CBD to THC, with a fixed dose of 2.7 mg THC and 2.5 mg CBD.
In May 2003 GW Pharmaceuticals and Bayer entered into an exclusive marketing agreement for GW’s cannabis-based medicinal extract product, to be marketed under the brand name Sativex. "Bayer has obtained exclusive rights to market Sativex in the UK. In addition, Bayer has the option for a limited period to negotiate the marketing rights in other countries in European Union and selected other countries around the world."
Nabiximols, as replacement therapy for marijuana, is a similar idea to nicotine replacement therapy for tobacco. Similar to nicotine withdrawal, cannabis withdrawal is known to contribute to relapse in individuals trying to quit marijuana. Such a medication would be highly relevant as there are currently no approved medicines for cannabis dependence.
Liebe Patientin, lieber Patient, hier finden Sie eine kurze filmische Darstellung der Möglichkeiten der medizinischen Verwendung von Cannabisprodukten in Deutschland, einerseits zur Verschreibung von Medikamenten auf Cannabisbasis (Sativex, Dronabinol und Nabilon) und andererseits zum Vorgehen bei einem Antrag auf eine Ausnahmeerlaubnis zur Verwendung von Cannabisblüten.
in dieser folge stelle ich das verschreibungspflichtige cannabis medikament SATIVEX vor. für dieses brauch man KEINE SONDERERLAUBNIS NACH § 3 Absatz 2 des BtmG - lediglich ein BTM rezept. und das habe ich selbstverständlich :P
Dr. Kantor talks about a study on a medication called Sativex.
Gw Pharm has made a spray based cannabis medicine
Sativex, el primer medicamento a base de marihuana en Colombia